Transfusion-free kidney transplantation in Jehovah’s witnesses: a propensity-score matched cohort study
Background Jehovah’s Witnesses (JWs) refuse blood transfusions on religious grounds, creating a major challenge in kidney transplantation (KT), where perioperative bleeding may necessitate transfusion support. Evidence regarding transfusion-free KT in JWs remains limited. We evaluated the feasibility and early clinical outcomes of a transfusion-free KT protocol in JW patients. Methods We performed a single-centre propensity score–matched cohort study including all JW recipients who underwent KT under a transfusion-free protocol between 2016 and 2025. The protocol included pre-transplant haemoglobin optimisation to ≥13 g/dL. JW recipients were matched 1:3 to non-JW controls based on recipient age and sex, donor type, and transplant date. Outcomes included peri-transplant transfusion, anaemia management, bleeding-related complications, and early post-transplant results. Results 27 JW recipients and 74 controls were included. Peri-transplant transfusion was completely avoided in JW recipients (0/27), whereas 24/74 controls (32.4%) required transfusion support. Bleeding-related complications occurred in 14.8% of JW recipients and 11.3% of controls (RR 1.65, 95% CI 0.44–6.21). Admission haemoglobin was higher in JW recipients (14.2 vs 11.5 g/dL; MD 2.69, 95% CI 2.15–3.22), as was nadir haemoglobin (10.0 vs 8.5 g/dL; MD 1.50, 95% CI 0.55–2.45). However, the absolute decrease from admission to nadir was greater in JW recipients (4.14 vs 3.01 g/dL; MD 1.13, 95% CI 0.21–2.06). Hospital stay was longer in JW recipients (MD 5.2 days, 95% CI −0.10 to 10.31). Conclusions A transfusion-free KT protocol was feasible in JW recipients managed at an experienced centre and enabled complete avoidance of peri-transplant transfusion. Early outcomes are reported descriptively and should be interpreted with caution because of the small sample size and residual imbalance between groups.
Authors
- Anna Buxeda (ORCID: https://orcid.org/0000-0001-7305-3259)
- Almudena Juez
- Carla Burballa (ORCID: https://orcid.org/0000-0002-0091-1459)
- Ignacio Cidraque
- Jesús Carazo (ORCID: https://orcid.org/0000-0002-1912-7189)
- Julio Pascual (ORCID: https://orcid.org/0000-0002-4735-7838)
- Albert Francés
- Lluís Cecchini
- Dolores Redondo Pachón
- María José Pérez Sáez
- Alexia Jiménez De Parga
- Betty Chamoun
- Marta Crespo
Institutions
- Universitat Pompeu Fabra (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Del Mar (ES)
- Hospital del Mar Research Institute (ES)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2026-11-03
- DOI
- https://doi.org/10.3389/fneph.2026.1938525
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00